CompuGroup Medical SE & Co. KGaA (COP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, CompuGroup Medical SE & Co. KGaA (COP) has a cash flow conversion efficiency ratio of 0.144x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€93.91 Million ≈ $109.79 Million USD) by net assets (€652.09 Million ≈ $762.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CompuGroup Medical SE & Co. KGaA defensive interval ratio to measure how many days the company can operate on defensive assets alone.
CompuGroup Medical SE & Co. KGaA - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how CompuGroup Medical SE & Co. KGaA's cash flow conversion efficiency has evolved over time, based on yearly financial data.
CompuGroup Medical SE & Co. KGaA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of CompuGroup Medical SE & Co. KGaA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Graham Corporation
NYSE:GHM
|
-0.001x |
|
Shanghai Film Co Ltd
SHG:601595
|
0.000x |
|
Shenzhen Sunrise New Energy Co Ltd
SHE:002256
|
0.036x |
|
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
|
N/A |
|
Parksystems Corp
KQ:140860
|
0.014x |
|
Lithium Argentina AG
NYSE:LAR
|
-0.008x |
|
Barloworld Ltd
JSE:BAW
|
0.282x |
|
Compass Minerals International Inc
NYSE:CMP
|
0.720x |
Annual Cash Flow Conversion Efficiency for CompuGroup Medical SE & Co. KGaA (2004–2024)
The table below shows the annual cash flow conversion efficiency of CompuGroup Medical SE & Co. KGaA from 2004 to 2024. For the full company profile with market capitalisation and key ratios, see COP market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €648.31 Million ≈ $757.94 Million |
€128.88 Million ≈ $150.68 Million |
0.199x | -25.89% |
| 2023-12-31 | €669.27 Million ≈ $782.45 Million |
€179.53 Million ≈ $209.89 Million |
0.268x | +24.63% |
| 2022-12-31 | €673.82 Million ≈ $787.77 Million |
€145.03 Million ≈ $169.55 Million |
0.215x | -20.26% |
| 2021-12-31 | €612.28 Million ≈ $715.82 Million |
€165.27 Million ≈ $193.22 Million |
0.270x | +15.03% |
| 2020-12-31 | €638.94 Million ≈ $746.98 Million |
€149.93 Million ≈ $175.29 Million |
0.235x | -44.80% |
| 2019-12-31 | €259.92 Million ≈ $303.87 Million |
€110.50 Million ≈ $129.18 Million |
0.425x | -14.88% |
| 2018-12-31 | €273.00 Million ≈ $319.16 Million |
€136.35 Million ≈ $159.41 Million |
0.499x | +37.37% |
| 2017-12-31 | €236.06 Million ≈ $275.98 Million |
€85.82 Million ≈ $100.34 Million |
0.364x | +17.57% |
| 2016-12-31 | €218.65 Million ≈ $255.63 Million |
€67.61 Million ≈ $79.05 Million |
0.309x | -18.69% |
| 2015-12-31 | €192.61 Million ≈ $225.18 Million |
€73.25 Million ≈ $85.63 Million |
0.380x | +109.11% |
| 2014-12-31 | €175.63 Million ≈ $205.33 Million |
€31.94 Million ≈ $37.34 Million |
0.182x | -33.05% |
| 2013-12-31 | €192.64 Million ≈ $225.21 Million |
€52.33 Million ≈ $61.18 Million |
0.272x | -27.15% |
| 2012-12-31 | €179.41 Million ≈ $209.75 Million |
€66.91 Million ≈ $78.22 Million |
0.373x | +34.21% |
| 2011-12-31 | €168.20 Million ≈ $196.65 Million |
€46.74 Million ≈ $54.64 Million |
0.278x | +25.74% |
| 2010-12-31 | €182.73 Million ≈ $213.63 Million |
€40.38 Million ≈ $47.21 Million |
0.221x | -6.68% |
| 2009-12-31 | €185.83 Million ≈ $217.25 Million |
€44.00 Million ≈ $51.45 Million |
0.237x | +67.08% |
| 2008-12-31 | €182.82 Million ≈ $213.74 Million |
€25.91 Million ≈ $30.29 Million |
0.142x | +11.41% |
| 2007-12-31 | €198.02 Million ≈ $231.50 Million |
€25.19 Million ≈ $29.45 Million |
0.127x | -58.08% |
| 2006-12-31 | €54.37 Million ≈ $63.57 Million |
€16.50 Million ≈ $19.29 Million |
0.303x | -43.26% |
| 2005-12-31 | €44.98 Million ≈ $52.59 Million |
€24.06 Million ≈ $28.13 Million |
0.535x | -31.38% |
| 2004-12-31 | €28.87 Million ≈ $33.76 Million |
€22.51 Million ≈ $26.31 Million |
0.779x | -- |
About CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA provides e-health services in Germany, Western and Eastern Europe, North America, and internationally. It operates through Ambulatory Information Systems (AIS), Hospital Information Systems (HIS), and Pharmacy Information Systems (PCS) segments. The Ambulatory Information Systems segment develops and sells management software for registered physicians, medical car… Read more